We aim to design a new world of proteins to address 21st century challenges in medicine, energy, and technology.
A group of scientists, lead by Ingrid Swanson Pultz, has designed an enzyme to combat celiac disease. Known as KumaMax, it is engineered to target and break down gluten, combating the body’s response. Further research and testing is needed before it is ready for the public, but it holds much promise as a future treatment.
Beyond the Institute
From Research Into Company
One of the first spin outs from the IPD was Cyrus Biotechnology, which is led by three former members (Lucas Nivon, Yifan Song, and Javier Castellanos). Their goal is to make protein design better by offering a software that is user friendly and powerful.
We know that computers are smart, but they can sometimes miss important things because of the way they are programmed. The same goes for researchers! This is where Foldit comes in: everyday people can play and help us discover better protein designs through their unique creativity and ingenuity.